Another thing I guess they are super strong in signing deals all deals since 2007 have been multi-target (so I guess similar to what Jannsen may expand to for PYC after the initial stage) and every company has come back for subsequent deals. New flow or advancement of programs is far greater than what's happening here - in first 6 months of this year alone Peptidream has signed deals with Ispen, extensions with Novartis, 2 new deals plus a milestone with Bristol Myers Squibb & expansion on the Amgen deal --- like a rocket.
Another thing I guess they are super strong in signing deals all...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
-0.040(3.03%) |
Mkt cap ! $746.5M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.35 | $1.28 | $764.7K | 579.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4000 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 40248 | 3 |
View Market Depth
| Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |